5 completed. 4 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Seed Health: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized, Double-Blind Placebo-Controlled Trial to Assess Overall User Experience of a Synbiotic Vaginal Suppository VH-01 vaginal suppository tablet, Placebo vaginal suppository tablet - Vaginal Personal Care | Not applicable | Completed | Seed Health | 200 | 2024-01-29 | 2025-05-31 |
| Randomized, Double-blind, Placebo-controlled Trial Investigating the Role of a Personal Care Product on Vaginal Health VM-02, Commercial Oral Probiotic Competitor, VM-02 Placebo - Vaginal Personal Care | Not applicable | Completed | Seed Health | 70 | 2022-12-05 | 2023-05-31 |
| SH-DS01 on Fecal Metagenomic Stability DS-01 - Irritable Bowel Syndrome | Phase 2 | Completed | Beth Israel Deaconess Medical Center | 48 | 2020-10-20 | 2026-02-17 |
| Tolerability and Functional Assessment of a Novel Children's Synbiotic PDS-08, Placebo - Constipation, Signs and Symptoms | Not applicable | Completed | Seed Health | 64 | 2020-08-13 | 2022-10-25 |
| Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic Therapy Ciprofloxacin + Metronidazole, SH-DS01, Placebo - Antibiotic Side Effect, Antibiotic-associated Diarrhea | Not applicable | Completed | Seed Health | 46 | 2020-08-12 | 2022-10-25 |
Constipation (1) · Dysbiosis (1) · Irritable Bowel Syndrome (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1) · Vaginal Discharge (1)
Ciprofloxacin (1) · Metronidazole (1)
United States (4) · Canada (1)
Anthony J Lembo, MD (1) · Charles Baum, MD (1) · Dirk Gevers, PhD (1) · Gregor Reid, PhD (1)